Wall Street analysts predict that Steris Plc (NYSE:STE) will report $0.96 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Steris Plc’s earnings, with the highest EPS estimate coming in at $1.00 and the lowest estimate coming in at $0.92. Steris Plc reported earnings per share of $0.89 in the same quarter last year, which suggests a positive year-over-year growth rate of 7.9%. The company is expected to announce its next quarterly earnings report on Wednesday, November 1st.

According to Zacks, analysts expect that Steris Plc will report full-year earnings of $4.06 per share for the current year, with EPS estimates ranging from $4.05 to $4.08. For the next financial year, analysts expect that the company will post earnings of $4.53 per share, with EPS estimates ranging from $4.51 to $4.57. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Steris Plc.

Steris Plc (NYSE:STE) last announced its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.80 by $0.05. The firm had revenue of $608.00 million during the quarter, compared to analyst estimates of $597.66 million. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. Steris Plc’s revenue was down 4.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.79 EPS.

A number of analysts have recently weighed in on the company. Wellington Shields lowered Steris Plc from a “gradually accumulate” rating to a “hold” rating in a research note on Monday, June 5th. BidaskClub lowered Steris Plc from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Raymond James Financial, Inc. raised their target price on Steris Plc from $90.00 to $95.00 and gave the company an “outperform” rating in a research note on Wednesday, August 9th. Finally, Zacks Investment Research upgraded Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 target price for the company in a research note on Tuesday, July 11th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average target price of $86.75.

In other Steris Plc news, Director Richard Martin Steeves sold 156,072 shares of the company’s stock in a transaction on Friday, September 8th. The stock was sold at an average price of $87.13, for a total value of $13,598,553.36. Following the transaction, the director now directly owns 9,362 shares of the company’s stock, valued at approximately $815,711.06. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the company’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $85.69, for a total value of $856,900.00. Following the completion of the transaction, the chief executive officer now directly owns 83,270 shares in the company, valued at $7,135,406.30. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 179,881 shares of company stock worth $15,608,811. Insiders own 2.55% of the company’s stock.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Janus Capital Management LLC grew its holdings in Steris Plc by 0.4% in the 1st quarter. Janus Capital Management LLC now owns 8,669,694 shares of the medical equipment provider’s stock valued at $602,192,000 after buying an additional 33,758 shares in the last quarter. Janus Henderson Group PLC grew its holdings in Steris Plc by 1,972.4% in the 2nd quarter. Janus Henderson Group PLC now owns 7,679,507 shares of the medical equipment provider’s stock valued at $625,880,000 after buying an additional 7,308,950 shares in the last quarter. BlackRock Inc. grew its holdings in Steris Plc by 33.4% in the 2nd quarter. BlackRock Inc. now owns 7,032,984 shares of the medical equipment provider’s stock valued at $573,188,000 after buying an additional 1,760,879 shares in the last quarter. Vanguard Group Inc. grew its holdings in Steris Plc by 1.6% in the 2nd quarter. Vanguard Group Inc. now owns 6,879,760 shares of the medical equipment provider’s stock valued at $560,700,000 after buying an additional 107,644 shares in the last quarter. Finally, Wellington Management Group LLP grew its holdings in Steris Plc by 77.8% in the 1st quarter. Wellington Management Group LLP now owns 6,529,610 shares of the medical equipment provider’s stock valued at $453,547,000 after buying an additional 2,856,744 shares in the last quarter. 94.67% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Steris Plc (NYSE:STE) traded down 0.316% during trading on Thursday, reaching $86.815. 37,141 shares of the company were exchanged. Steris Plc has a 52-week low of $63.80 and a 52-week high of $88.11. The stock has a market capitalization of $7.40 billion, a P/E ratio of 62.099 and a beta of 1.29. The stock has a 50-day moving average of $85.01 and a 200 day moving average of $77.70.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th will be issued a $0.31 dividend. This represents a $1.24 dividend on an annualized basis and a yield of 1.42%. This is a positive change from Steris Plc’s previous quarterly dividend of $0.28. The ex-dividend date of this dividend is Friday, August 25th. Steris Plc’s dividend payout ratio is currently 88.57%.

COPYRIGHT VIOLATION WARNING: “Zacks: Analysts Anticipate Steris Plc (STE) Will Announce Earnings of $0.96 Per Share” was posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.americanbankingnews.com/2017/09/14/zacks-analysts-anticipate-steris-plc-ste-will-announce-earnings-of-0-96-per-share.html.

Steris Plc Company Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Get a free copy of the Zacks research report on Steris Plc (STE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Steris Plc (NYSE:STE)

Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.